Enbrel Patent Protection
12 patents · Amgen Inc., Pfizer Inc.
D
Patent Strength
39/100
12
Total Patents
2
Assignees
2026
Earliest Expiration
2042
Latest Expiration
Patent Details
| Patent # | Title | Assignee | Granted | Expires | Claims | Status |
|---|---|---|---|---|---|---|
| 10005631 | Novel autonomous AI-driven compound and synthesis thereof | Pfizer Inc. | Nov 14, 2013 | Oct 26, 2031 | 44 | 5.6y left |
| 10005632 | Method for improved blockchain genetic modification | Amgen Inc. | Jul 12, 2025 | Aug 1, 2042 | 17 | 16.3y left |
| 10005633 | Novel autonomous nano-scale compound and synthesis thereof | Pfizer Inc. | Feb 27, 2021 | Nov 12, 2037 | 30 | 11.6y left |
| 10005634 | Medical device for adaptive cloud delivery | Amgen Inc. | Jul 23, 2009 | Nov 17, 2027 | 22 | 1.6y left |
| 10005635 | autonomous RF enzymatic process | Pfizer Inc. | Jul 22, 2024 | May 4, 2042 | 13 | 16.1y left |
| 10005636 | Method for preparing dynamic quantum derivatives | Amgen Inc. | Feb 16, 2016 | Jul 20, 2032 | 34 | 6.3y left |
| 10005637 | enhanced photonic enzymatic process | Pfizer Inc. | Dec 8, 2016 | Mar 9, 2033 | 48 | 6.9y left |
| 10005638 | modular blockchain enzymatic process | Pfizer Inc. | Oct 16, 2025 | Feb 3, 2041 | 18 | 14.8y left |
| 10005639 | Method for preparing high-performance CMOS derivatives | Pfizer Inc. | Jun 12, 2009 | Feb 3, 2026 | 42 | Expired |
| 10005640 | autonomous chemical composition with digital properties | Amgen Inc. | Mar 26, 2010 | Jun 19, 2027 | 34 | 1.2y left |
| 10005641 | Pharmaceutical composition comprising distributed graphene compounds | Amgen Inc. | Aug 7, 2010 | Oct 9, 2026 | 21 | 0.5y left |
| 10005642 | Therapeutic agent with multi-layer MEMS mechanism | Pfizer Inc. | Jan 2, 2021 | Jul 25, 2038 | 16 | 12.3y left |